Experimental Medicine for HIV Vaccine Research and Development
The development of safe and effective HIV vaccines has been a scientific challenge for more than 40 years. Despite disappointing results from efficacy clinical trials, much has been learnt from years of research and development. In a rapidly evolving HIV prevention landscape, swift evaluation of mul...
Main Authors: | Holly Prudden, Roger Tatoud, Cathy Slack, Robin Shattock, Pervin Anklesaria, Linda-Gail Bekker, Susan Buchbinder |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-05-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/11/5/970 |
Similar Items
-
Gender aspects on HIV prevention efforts and participation in HIV vaccine trials among Police officers in Dar es Salaam, Tanzania
by: Edith A. M. Tarimo, et al.
Published: (2018-07-01) -
Participants’ characteristics and motivations to screen for HIV vaccine and monoclonal antibody trials in KwaZulu-Natal, South Africa
by: Jill Hanass-Hancock, et al.
Published: (2021-12-01) -
An HIV vaccine: how and when?
by: Esparza José
Published: (2001-01-01) -
Sexual reproductive healthcare utilisation and HIV testing in an integrated adolescent youth centre clinic in Cape Town, South Africa
by: Andrea S. Mendelsohn, et al.
Published: (2018-11-01) -
What motivates participation in HIV cure trials? A call for real-time assessment to improve informed consent
by: Holly L. Peay, et al.
Published: (2015-01-01)